199 related articles for article (PubMed ID: 15624859)
41. Pathogenesis of Helicobacter pylori infection.
Cid TP; Fernández MC; Benito Martínez S; Jones NL
Helicobacter; 2013 Sep; 18 Suppl 1():12-7. PubMed ID: 24011239
[TBL] [Abstract][Full Text] [Related]
42. Relation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori-infected patients from The Netherlands.
Pan ZJ; van der Hulst RW; Tytgat GN; Dankert J; van der Ende A
Am J Gastroenterol; 1999 Jun; 94(6):1517-21. PubMed ID: 10364017
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of CagA and VacA antibodies in children with Helicobacter pylori-associated peptic ulcer compared to prevalence in pediatric patients with active or nonactive chronic gastritis.
Alarcón T; Martínez MJ; Urruzuno P; Cilleruelo ML; Madruga D; Sebastian M; Domingo D; Sanz JC; López-Brea M
Clin Diagn Lab Immunol; 2000 Sep; 7(5):842-4. PubMed ID: 10973467
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxin-associated gene A and vacuolating cytotoxin A in human isolates of Helicobacter pylori and their association with the clinical status of ulcer disease.
Carattoli A; Pezzella C; Pietroiusti A; Galante A; Pezzotti P; Luzzi I
Eur J Gastroenterol Hepatol; 2000 Nov; 12(11):1207-13. PubMed ID: 11111777
[TBL] [Abstract][Full Text] [Related]
45. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
46. CagA-mediated pathogenesis of Helicobacter pylori.
Tohidpour A
Microb Pathog; 2016 Apr; 93():44-55. PubMed ID: 26796299
[TBL] [Abstract][Full Text] [Related]
47. Serologic detection of CagA positive Helicobacter pylori strains predicts the presence of peptic ulcer in young dyspeptic patients.
Rokkas T; Liatsos C; Karameris A; Petridou E; Papatheodorou G; Kalafatis E
Gastrointest Endosc; 1999 Oct; 50(4):511-5. PubMed ID: 10502172
[TBL] [Abstract][Full Text] [Related]
48. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
Chen XJ; Yan J; Shen YF
Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter pylori cagA status, vacA genotypes and ulcer disease.
Stephens JC; Stewart JA; Folwell AM; Rathbone BJ
Eur J Gastroenterol Hepatol; 1998 May; 10(5):381-4. PubMed ID: 9619383
[TBL] [Abstract][Full Text] [Related]
50. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.
Peters TM; Owen RJ; Slater E; Varea R; Teare EL; Saverymuttu S
J Clin Pathol; 2001 Mar; 54(3):219-23. PubMed ID: 11253135
[TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori factors associated with disease development.
Mobley HL
Gastroenterology; 1997 Dec; 113(6 Suppl):S21-8. PubMed ID: 9394755
[TBL] [Abstract][Full Text] [Related]
52. cagA vacA alelles and babA2 genotypes of Helicobacter pylori associated with gastric disease in Brazilian adult patients.
Gatti LL; Fagundes e Souza EK; Leite KR; Bastos EL; Vicentini LR; Silva LC; Smith Mde A; Payão SL
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):231-5. PubMed ID: 15808313
[TBL] [Abstract][Full Text] [Related]
53. [Relationship between CagA-bearing strains of Helicobacter pylori and gastrointestinal pathology].
Reshetnikov OV; Kurilovich SA; Krotov SA; Krotova VA; Shumakov OV
Ter Arkh; 2005; 77(2):25-8. PubMed ID: 15807446
[TBL] [Abstract][Full Text] [Related]
54. [The heterogeneity of genetic variants of Helicobacter pylori in patients with various acid-related diseases].
Domracheva EV; Sarsenbaeva AS; Ufimtsev KA
Eksp Klin Gastroenterol; 2014; (11):8-13. PubMed ID: 25842656
[TBL] [Abstract][Full Text] [Related]
55. CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.
Harris PR; Godoy A; Arenillas S; Riera F; García D; Einisman H; Peña A; Rollán A; Duarte I; Guiraldes E; Perez-Perez G
J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):596-602. PubMed ID: 14581804
[TBL] [Abstract][Full Text] [Related]
56. Relationship between vacA Types and Development of Gastroduodenal Diseases.
Thi Huyen Trang T; Thanh Binh T; Yamaoka Y
Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27294955
[TBL] [Abstract][Full Text] [Related]
57. Novel activities of the Helicobacter pylori vacuolating cytotoxin: from epithelial cells towards the immune system.
Fischer W; Gebert B; Haas R
Int J Med Microbiol; 2004 Apr; 293(7-8):539-47. PubMed ID: 15149029
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration.
Hida N; Shimoyama T; Neville P; Dixon MF; Axon AT; Shimoyama T; Crabtree JE
J Clin Pathol; 1999 Sep; 52(9):658-64. PubMed ID: 10655986
[TBL] [Abstract][Full Text] [Related]
59. Helicobacter pylori vacA genotypes and cagA gene in a series of 383 H. pylori-positive patients.
Rudi J; Kuck D; Rudy A; Sieg A; Maiwald M; Stremmel W
Z Gastroenterol; 2000 Jul; 38(7):559-64. PubMed ID: 10965552
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia.
Takata T; Fujimoto S; Anzai K; Shirotani T; Okada M; Sawae Y; Ono J
Am J Gastroenterol; 1998 Jan; 93(1):30-4. PubMed ID: 9448169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
